GlobeNewswire Inc.··Fibrobiologics, Inc.FibroBiologics Advances Clinical Pipeline With cGMP Manufacturing, Raises $3M
FibroBiologics completes cGMP manufacturing for lead candidate CYWC628, expects first patient dosing Q2 2026 in diabetic foot ulcer trial. Company raises $3M and maintains $1.5M cash.
FBLGcapital raisepreclinical results